3,127
Views
33
CrossRef citations to date
0
Altmetric
Research Article

pH-responsive carbon nanotube-based hybrid nanogels as the smart anticancer drug carrier

, &
Pages 1437-1443 | Received 13 Jan 2019, Accepted 09 Mar 2019, Published online: 16 Apr 2019

Figures & data

Figure 1. Schematic view of the whole synthesis, drug loading and release behaviour of the hybrid magnetic CNT in the tumour microenvironment.

Figure 1. Schematic view of the whole synthesis, drug loading and release behaviour of the hybrid magnetic CNT in the tumour microenvironment.

Figure 2. SEM images of the (A) f-CNT and (B) hybrid Chi-MnFe2O4/CNT, Scale bare is 100 nm. C) XRD analysis of the hybrid Chi-MnFe2O4/CNT sample.

Figure 2. SEM images of the (A) f-CNT and (B) hybrid Chi-MnFe2O4/CNT, Scale bare is 100 nm. C) XRD analysis of the hybrid Chi-MnFe2O4/CNT sample.

Figure 3. (A) FTIR spectra of the (I) f-CNT and (II) Chi- MnFe2O4/CNT samples. (B) VSM plot of the MnFe2O4, Chitosan coated MnFe2O4 and the hybrid Chi- MnFe2O4/CNT samples.

Figure 3. (A) FTIR spectra of the (I) f-CNT and (II) Chi- MnFe2O4/CNT samples. (B) VSM plot of the MnFe2O4, Chitosan coated MnFe2O4 and the hybrid Chi- MnFe2O4/CNT samples.

Figure 4. (A) Zeta potential analysis of the samples (B) before magnetic decoration, f-CNT and (C) after magnetic decoration, Chi-MnFe2O4/CNT. (E) Effect of magnetic decoration on the hydrodynamic diameter of the f-CNT.

Figure 4. (A) Zeta potential analysis of the samples (B) before magnetic decoration, f-CNT and (C) after magnetic decoration, Chi-MnFe2O4/CNT. (E) Effect of magnetic decoration on the hydrodynamic diameter of the f-CNT.

Figure 5. Cumulative release profile of the (A) Chi- MnFe2O4/CNT and (B) f-CNT samples in two experimental pH of 5.3 and 7.

Figure 5. Cumulative release profile of the (A) Chi- MnFe2O4/CNT and (B) f-CNT samples in two experimental pH of 5.3 and 7.

Figure 6. Live-Dead fluorescent imaging of the U-87 gliobalastoma cell line (A) without drug and (B–E) after drug applying. (G) MTT profile of the drug affected U-87 gliobalastoma cells at each time intervals.

Figure 6. Live-Dead fluorescent imaging of the U-87 gliobalastoma cell line (A) without drug and (B–E) after drug applying. (G) MTT profile of the drug affected U-87 gliobalastoma cells at each time intervals.